Operating Lease, Right-of-Use Asset of Citius Pharmaceuticals, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Citius Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Citius Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $818,694, a 232% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Citius Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $818,694 +$572,447 +232% 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q2 2025 $880,732 +$580,800 +194% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 $922,099 +$569,594 +162% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 $191,412 -$212,584 -53% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 $246,247 -$208,179 -46% 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q2 2024 $299,932 -$203,885 -40% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q3
Q1 2024 $352,505 -$199,700 -36% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $403,996 -$195,621 -33% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 $454,426 -$191,648 -30% 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 $503,817 -$187,776 -27% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 $552,205 -$184,004 -25% 31 Mar 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 $599,617 -$180,332 -23% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q1
Q3 2022 $646,074 -$176,754 -21% 30 Sep 2022 10-K 29 Dec 2023 2023 FY
Q2 2022 $691,593 -$173,272 -20% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 $736,209 -$169,883 -19% 31 Mar 2022 10-Q 12 May 2022 2022 Q2
Q4 2021 $779,949 -$166,584 -18% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q1
Q3 2021 $822,828 -$163,376 -17% 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q2 2021 $864,865 -$160,254 -16% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q3
Q1 2021 $906,092 -$149,785 -14% 31 Mar 2021 10-Q 13 May 2021 2021 Q2
Q4 2020 $946,533 -$156,622 -14% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q1
Q3 2020 $986,204 -$151,796 -13% 30 Sep 2020 10-K 15 Dec 2021 2021 FY
Q2 2020 $1,025,119 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 $1,055,877 31 Mar 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 $1,103,155 31 Dec 2019 10-Q 13 Feb 2020 2020 Q1
Q3 2019 $1,138,000 30 Sep 2019 10-K 16 Dec 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.